title: Loss of tyrosine hydroxylase expression within the nigro-striato-cortical pathways in the cirrhotic rat: the possible restorative effect of the neurosteroid dehydroepiandrosterone sulfate.
abstract: Hepatic encephalopathy (HE) is a neuropsychiatric disorder occurring as a consequence of both acute and chronic liver failure. Advanced HE is generally accompanied with extrapyramidal symptoms including rigidity and tremor, which may reflect alterations of the dopaminergic system. Recently we reported a beneficial effect of the neuroactive steroid dehydroepiandrosterone sulfate (DHEAS) in cirrhotic rats, however the mechanisms of such an effect by DHEAS were not addressed. In the present study, we describe the changes of the dopaminergic system occurring in the cirrhotic rats and concomitantly we investigated the effect of DHEAS on this system in Sprague-Dawley rats using the expression of tyrosine hydroxylase (TH) as a neuronal marker. Rats were submitted to bile duct ligation (BDL) surgery and TH immunohistochemistry was assessed in the Substantia nigra pars compacta (SNc), striatum, ventral tegmental area (VTA) and the cortex. TH immunoreactivity showed a significant diminution in both SNc and VTA concomitantly with the cortical and the striatal outputs in the BDL rats vs. controls. Three daily injections of 5mg/kg of DHEAS to BDL rats significantly normalized TH expression decrease in both SNc and VTA as well as dopaminergic projections to the striatum and the cortex of BDL rats. The present data support an involvement of the dopaminergic system in mild HE and a possible beneficial effect of the neurosteroid DHEAS as a potential pharmacological treatment of mild HE.
authors: Neurosciences, Pharmacology and Environment Unit, Faculty of Sciences Semlalia, Cadi University Ayyad, Marrakesh, Morocco.
authors: Omar
authors: O
authors: El Hiba
authors: Halima
authors: H
authors: Gamrani
authors: Hicham
authors: H
authors: Chatoui
authors: Samir
authors: S
authors: Ahboucha
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D001928:Brain Diseases, Metabolic / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology; D002540:Cerebral Cortex / Q000201:enzymology; D003342:Corpus Striatum / Q000201:enzymology; D019314:Dehydroepiandrosterone Sulfate / Q000494:pharmacology*; D004195:Disease Models, Animal; D007150:Immunohistochemistry / Q000379:methods; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013378:Substantia Nigra / Q000201:enzymology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*; D017557:Ventral Tegmental Area / Q000201:enzymology
chemical_list: D015415:Biomarkers; D019314:Dehydroepiandrosterone Sulfate; D014446:Tyrosine 3-Monooxygenase
keywords: Cirrhosis; Dehydroepiandrosterone sulfate; Rat; Substantia nigra pars compacta; Tyrosine hydroxylase; Ventral tegmental area